Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-25

Clinical Trial Update: taVNS in Mild to Moderate Parkinson's Disease [NA]

View source ↗

Summary

Completed clinical trial of transcutaneous auricular vagus nerve stimulation (taVNS) in mild to moderate Parkinson's disease with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Parkinson Disease | NA | Status: COMPLETED | Results posted: 2023-01-25